Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists, according to a University at Buffalo-led study.
No more worries for diabetics with weak muscles. The Metallurgy and Materials Science Research Institute, Chulalongkorn University will soon launch a cutting-edge, health innovation – a wristwatch that can check blood sugar levels from sweat in real-time. It’s accurate, not painful, less expensive, and can replace imported equipment. It is expected to be available on the market soon.
Diabetes organizations collaborate to offer mentored fellowship in integrated diabetes management. Applications must be submitted by July 31, 2020.
Researchers at the Icahn School of Medicine at Mount Sinai have discovered a novel combination of two classes of drugs that, together, cause the highest rate of proliferation ever observed in adult human beta cells—the cells in the pancreas that produce insulin—without harming most other cells in the body. The result is an important step toward a diabetes treatment that restores the body’s ability to produce insulin.
ANN ARBOR, Mich. – Having diabetes is a risk factor for many other health conditions, including stroke. “Every 40 seconds an American has a stroke,” says Frederick Korley, M.D., Ph.D., an assistant professor of emergency medicine at Michigan Medicine. “To be…